Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
To investigate the expression of microRNA (miRNA-137) in oral squamous cell carcinoma (OSCC) and its effects on activity, invasion and proliferation of OSCC human squamous cell carcinoma cell lines 2 (HSC-2 cell line). 158 cases of pathologically-confirmed OSCC tissues and corresponding para-cancerous tissues were collected. The tissue mRNA was extracted and miRNA-137 expression in tissues was detected using real-time polymerase chain reaction (RT-PCR). With miRNA-137 mimics and scramble mimics transfected into OSCC HSC-2 cells, invasion and proliferation of cells were measured with Transwell assay, and cell viability was measured with methyl thiazolyl tetrazolium (MTT) assay. The relationship miRNA-137 expression in OSCC tissues and cell invasion, proliferation and viability with clinicopathological parameters were recorded and analyzed. The expression of miRNA-137 in OSCC tissues was significantly lower than that in adjacent tissues (p=0.0057). Compared with untreated OSCC HSC-2 cells, the expression of miRNA-137 was significantly increased in OSCC HSC-2 cells treated with miRNA-137 mimics, and the difference was statistically significant (p<0.05). No statistically significant difference was detected when comparing the miRNA-137 expression between the untreated OSCC HSC-2 cells and OSCC HSC-2 cells treated with scramble simulation (p>0.05). The cell viability, invasion and proliferation of OSCC HSC-2 treated with miRNA-137 mimics were significantly lower than those of untreated OSCC HSC-2 cells and scramble simulation-treated OSCC HSC-2 cells (p<0.05). The miRNA-137 expression in OSCC tissue was significantly relevant with World Health Organization (WHO) pathological grading and the history of areca nut use (p=0.044), but miRNA-137 expression showed no correlation with the patient's gender, age, TNM stage, smoking and lymph node metastasis (p>0.05). miRNA-137 is lowly expressed in OSCC tissues, which is related to tumor differentiation. MiRNA-137 is expected to be a potential marker for early diagnosis of OSCC.